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Abstract 
Wnt signalling is critically involved in the differentiation of human Mesenchymal Stem Cells 
(hMSC). Wnt proteins therefore have considerable therapeutic value, but are expensive and 
difficult to produce. UM206 is a synthetic peptide and ligand for the Wnt receptor Frizzled. 
Attachment of UM206 to magnetic nanoparticles (MNP) enables the ligand-MNP complex to 
be manipulated using magnetic fields, allowing control of Frizzled stimulation. Using this 
approach, Wnt signalling was activated in hMSC which resulted in Frizzled clustering, β-
catenin translocalisation and activation of TCF/LEF responsive transcription. During 
osteogenesis, UM206-MNP initiated localised mineralised matrix formation. Injection and 
magnetic stimulation of UM206-MNP-labelled MSC in ex vivo chick femurs resulted in 
increased mineralisation which acted synergistically with addition of bone morphogenic 
protein 2 (BMP2) releasing micro-particles. As this facilitates external control over signal 
transduction, conjugated MNP technology has applications both as a research tool and for 
regulating tissue formation in clinical cell therapies. 
Key words: Mesenchymal stem cells; Magnetic nanoparticles; Wnt signalling; bone tissue 
engineering 
Background 
Human mesenchymal stem cells (hMSC) are a promising source for autologous cell 
therapies, particularly for orthopaedic tissue engineering [1]. MSC differentiation into 
osteoblasts results from an array of signalling cascades which are triggered by growth factors, 
physical and environmental stimuli which cross-talk with each other. These stimuli alter the 
expression of numerous regulatory factors including Wnt proteins. MSC have been shown to 
express a range of Wnt proteins and receptors and the pathway is a pivotal regulator of hMSC 
fate and osteoblast differentiation [2], [3].  
Wnt signalling pathways have a multitude of effects on cell behaviour including changes to 
polarity and differentiation. The effects are dependent on cell type and Wnt protein context 
[4], [5]. For example activation of canonical signalling has been shown to promote hMSC 
proliferation, preserve multipotency and inhibit differentiation [6], [7]. However over-
expression of the Wnt co-receptor LRP5 and active β-catenin has also been shown to promote 
osteogenic differentiation of hMSC [8]. Recently, we have demonstrated that immobilised 
Wnt molecules influence MSC migration and differentiation in 3D in vitro models [9]. In 
vivo, Wnt3A enhances skeletal progenitor cell proliferation, differentiation and accelerates 
bone repair in Axin2 knockout mice [10].  
Despite the significant role of Wnt in directing tissue formation, its use in vivo for bone repair 
has been limited. This is partly due to the complex and costly production methods required to 
produce pharmacological quantities of bioactive Wnt with the appropriate post-translational 
modifications [11], [12]. Therefore, there is considerable interest in developing synthetic Wnt 
analogues to pharmacologically regulate Wnt signalling for therapeutic use. UM206 is a 
synthetic peptide based on a conserved fragment of Wnt3A and Wnt 5A. UM206 is a specific 
ligand for Frizzled1 and Frizzled2 receptors and is capable of activating canonical Wnt 
signalling depending on its conformation [13]. 
The use of magnetic nanoparticles (MNP) to target cell signalling pathways is an expanding 
research area in biomedical research. Our previous work has demonstrated the efficacy of 
remotely activating Wnt signalling using oscillating magnetic fields with antibody-coated 
MNP targeted against Frizzled2 receptors [14]. The use of magnetite MNP for biomedical 
applications is particularly attractive due to the level of control that can be excised over 
particle shape, size, charge, coating, magnetization and dose [15]. MNP have been used for 
biomedical applications such as control of cell function and positioning in conjunction with 
magnetic fields. This can enable formation of heterotypic co-culture cell layers and complex 
tissue formation [16], [17]. Incorporation of growth factor conjugated magnetite MNP into 
silk fibroin scaffolds has also shown efficacy in bone tissue engineering [18]. From a clinical 
perspective, the translational potential of magnetite based MNP is clear from their current use 
as MRI contrast agents [19]. A detailed review discussing the clinical applications of MNP in 
the context of orthopaedics is provided by Wimpenny et al [20]. We have demonstrated the 
potential applications of MNP in tissue engineering and regenerative medicine by targeting 
other mechanically responsive targets such as the TREK1 ion channel [21], [22], PDGF 
receptors [23] and Integrins [24]. 
In this study, we report on the feasibility of using synthetic peptide-MNP conjugates for 
remote signalling mechano-activation. Initially, we have demonstrated the mechanism of 
Frizzled signal transduction and Wnt pathway activation via UM206-conjugated MNP and 
oscillating magnetic fields in hMSC using reporter systems. The potential use of UM206-
conjugated MNP for directing bone formation remotely was then assessed using in vitro 
monolayer and 3D (ex vivo) foetal chick femur models [25], [26]. The synergistic effects of 
MNP-mediated Wnt activation and BMP2 signalling on bone formation were also 
investigated. The overall aim of this research was to demonstrate that remote activation of 
Wnt signalling pathways in mesenchymal cell progenitors using peptide conjugated MNP can 
regulate remote controlled bone tissue formation. This technique has applications in both in 
vitro basic research and in orthopaedic cell therapies. 
 
Methods  
Cell culture. hMSC were isolated from fresh bone marrow (Lonza) as described in 
supplementary methods. Cells were expanded in basal media (10% FBS, 1% L-glutamine and 
1% penicillin/streptomycin) (Lonza). Media was replaced twice per week and cells P1-5 were 
used in all experiments. Osteogenic media was prepared as described in supplementary 
methods. For Wnt-treated control groups diluted Wnt3A conditioned media collected from 
Wnt3A overexpressing L-M (TK-) cells (LGC standards) was used.  
Transient transfections. hMSC were transiently transfected with a Gaussia Luciferase 
reporter under control of a TCF/LEF promoter as described previously [14] and in 
supplementary methods. 
MNP coating. 250nm SPIO carboxyl functionalised MNP (Micromod) were covalently 
coated with UM206 peptide by carbodiimide activation as described previously [14] (Fig. 1a) 
and in supplementary methods. MNP coating was characterised as described in the 
supplementary methods. 
Cell labelling with MNP. Cells were cultured in reduced serum basal media for 3h prior to 
addition of 25µg MNP/2x10
5
 cells. Cells were incubated with MNP for 1.5h, then washed 
with PBS to remove unbound particles before addition of fresh media (Fig. 1b).     
Magnetic stimulation. Magnetically stimulated groups were treated with ≥25mT magnetic 
fields using an oscillating magnetic force bioreactor (MICA Biosystems) as described 
previously [14] (Fig 1c). Treatment was performed as described in supplementary methods. 
Cell viability staining. Cells were labelled with MNP and treated with magnetic field 
stimulation as described above. After 14 days treatment, cells were washed with PBS then 
stained with a Live/dead assay as described in supplementary methods. 
MTT assay. Cells were labelled with varying doses of L-/C-C-UM206-MNP or uncoated 
(blank) MNP (5μg to 300μg MNP/2x105 cells) or treated with varying doses of linear / cyclic 
UM206 peptide (1-100μg/mL). Magnetic field groups were treated with magnetic field 
stimulation as described above. After 14 days MTT assay was performed as described in 
supplementary methods. 
Immunocytochemistry. MNP labelling of cells, β-catenin and Osteocalcin staining were 
assessed using immunofluorescence as described in supplementary methods. 
Proximity ligation assay. Frizzled receptor clustering was assessed using a proximity ligation 
assay (PLA) (Duolink, Sigma). Cells were seeded onto glass coverslips (1cm
2
) and labelled 
with MNP as described above; magnetically stimulated groups were treated for 3h. Cells 
were fixed with 90% methanol and blocked as above and MNP and Frizzled2 were visualised 
by staining as described in supplementary methods. 
Luciferase reporter assays. Experiments were performed in reduced serum basal media. At 
each time point, media samples were taken and analysed for luciferase activity using a 
luciferase flash assay kit (Thermo Pierce) on a Biotek Synergy 2 plate reader. Luciferase 
activity was normalised to the total protein content of cell lysates. 
Chick femur culture and microinjection. Foetal chick femurs were extracted and treated as 
previously described [22] and in supplementary methods.  
BMP2 microparticle encapsulation. BMP2 microparticles were prepared as previously 
described [22] and in supplementary methods.  
X-ray microtomography. Chick  femurs were analysed using X-ray microtomography (µCT) 
as previously described [22] and in supplementary methods.  
Histology. For in vitro experiments cells were fixed as above, washed with d.H2O, then 
stained as described in supplementary materials. For chick femur experiments femurs were 
fixed in 4% paraformaldehyde for 48h,  stored in PBS, then stained and sectioned as 
described in supplementary methods.     
Immunohistochemistry. Femurs were processed as described in supplementary methods.  
Statistical analysis. All data is presented as means +/- SEM. Statistical significance at 95% 
Confidence level was determined using 1-way ANOVA with post-hoc Tukey tests using 
Mini-tab. μCT data was analysed by 1-way ANOVA with post-hoc Dunnett’s test, all groups 
were compared to the Sham injection (control) group. 
 
Results 
The MNP coating efficiency was first determined using total protein assay and physical 
characterisation. The amount of UM206 conjugated to MNP was estimated by measuring the 
protein content of the MNP coating solutions before and after incubation with activated 
MNP. The protein content of the coating solutions (ie. unbound protein) decreased by 
between 5% and 27% after incubation with the activated MNP (supplementary table 1).  The 
hydrodynamic size and charge of L- / C-C-UM206 functionalised MNP were compared to 
uncoated-MNP. The hydrodynamic size of L- / C-C-UM206-MNP increased to between 332-
345nm respectively, whilst surface charge increased to between -16 to -8mV. In contrast 
uncoated MNP had a hydrodynamic size of 299nm and a surface charge of -20mV 
(supplementary table 2). 
RT-PCR was then used to confirm Frizzled2 expression in hMSC. Frizzled2 was found to be 
stably expressed over 21 days in basal or osteogenic media (Supplementary Fig. 1a). 
Furthermore Frizzled2 expression was found to be unaffected 24h after treatment with L- / C-
C-UM206-MNP (with or without magnetic field treatment) or in response to Wnt-CM as 
shown by qPCR (supplementary fig 1b).  
Cell labelling with L- / C-C-UM206-MNP was then confirmed using immunofluorescence. A 
clear association between cells and MNP was observed after labelling with either MNP type 
(Fig. 2a). The viability and metabolism of hMSC bound with L- / C-C-UM206-MNP and 
exposed to oscillating magnetic fields was then assessed to determine any cytotoxic effects of 
MNP at a dose shown to induce signalling responses in hMSC. Live/Dead staining was used 
to determine intracellular esterase activity and cell membrane integrity 14 days after 
treatment. Cells remain viable after treatment with MNP (L-UM206-MNP or C-C-UM206-
MNP) with or without intermittent magnetic field stimulation (Fig. 2b). Magnetic field 
treatment alone also had no observable effect on cell viability. MTT assay was also used to 
assess changes in cell metabolism after 14 days treatment (Fig 2c). No overall effects were 
observed when cells were treated with MNP (L-UM206-MNP or C-C-UM206-MNP) with or 
without magnetic field stimulation or with magnetic field alone. A dose response study was 
also performed  (supplementary fig. 2). Cells were treated with varying doses of unbound 
Linear or Cyclic peptide (1-100μg/mL) or with varying doses of L-/C-C-UM206-MNP or 
uncoated (blank) MNP (5μg to 300μg/2x105 cells). No overall effect on cell metabolism was 
observed when cells were treated with either MNP or peptide in these dose ranges.  
Next, the effects of L- / C-C UM206-MNP on Wnt signalling were assessed. 
Immunocytochemistry was used to assess nuclear translocation of β-catenin. β-catenin 
mobilisation was enhanced in cells stimulated with Wnt3a-CM and L-UM206-MNP (and to a 
lesser extent with C-C-UM206-MNP), demonstrating that L-UM206-MNP are capable of 
stimulating β-catenin-mediated Wnt signal transduction (Fig 3A). This effect was enhanced 
when cells were treated with L-UM206-MNP and magnetic field oscillation (Fig. 3B). Next, 
the effects of L- / C-C-UM206-MNP on the activity of a Wnt TCF/LEF luciferase reporter 
which was transiently transfected into hMSC was determined. Six hours after magnetic field 
stimulation (or treatment with Wnt3a-CM), reporter activity was increased in all groups 
except for magnetic field only control and cells cultured with Wnt3a-CM and DKK1, a 
negative regulator of Wnt pathway activation (Fig. 3C(i)). DKK1 effectively inhibited 
Wnt3A signal transduction, but had no effect on L-UM206-MNP mediated activation. 
Furthermore, reporter activity was significantly higher when cells were treated with L-
UM206-MNP compared to Wnt3a-CM. At 24h, reporter activity in the control groups 
remained at low levels, whilst Wnt3a-CM significantly increased reporter activity. Reporter 
activity of L-UM206-MNP stimulated cells persisted 24h after application of the magnetic 
stimulus and again was not affected by DKK1. In contrast to L-UM206-MNP, C-C-UM206-
MNP had a negligible effect on Wnt-reporter activity compared to controls over both time-
points (Fig. 3C(ii)). 
The mechanism of Wnt pathway activation by UM206-MNP was probed further using a 
proximity ligation assay to determine the degree of Frizzled receptor clustering in response to 
MNP. A basal level of receptor clustering was observed in non-treated cells. Treatment with 
Wnt3a-CM or magnetic field alone had no observable effect on receptor clustering (Fig 4a). 
In contrast, a noticeable increase in localised receptor clusters was observed in distinct cell 
populations when cells were treated with L-UM206-MNP, indicating that part of the receptor 
signal activation may be due to receptor clustering. A reduced level of receptor clustering 
was observed in response to C-C-UM206-MNP. In contrast control-MNP coated with non-
specific IgG had no effect on receptor clustering (supplementary fig. 3a). Co-localisation 
analysis of MNP and Frizzled2 staining confirmed positive pixel overlap between MNP and 
Frizzled2 receptors in both L-UM206-MNP and C-C-UM206-MNP treated groups with or 
without magnetic field (Fig 4b). The extent of MNP/receptor co-localisation was quantified 
using Manders threshold coefficient which confirmed positive pixel overlap with values 
ranging from 0.31 (C-C-UM206-MNP) to 0.48 (L-UM206-MNP). In contrast negligible 
overlap was observed in IgG-MNP control groups (Manders threshold coefficient =0.025) 
(supplementary fig. 3b).  
The osteogenic response to remote activation of Frizzled2 using L-UM206-MNP was then 
assessed.  MSC labelled with L-UM206-MNP were cultured for 28 days in osteogenic media 
with intermittent magnetic stimulation. We observed that L-UM206-MNP treated cells 
formed localised areas of Collagen (Fig. 5A), calcified matrix (Fig. 5B) and Osteocalcin 
deposition (Fig. 5C) which were less apparent in the non-treated control group. An additive 
effect on localised matrix formation was observed when cells were treated with L-UM206-
MNP with magnetic stimulation. Under our conditions treatment with Wnt3a-CM caused 
increases in collagen synthesis and Osteocalcin production. 
A translational ex vivo foetal chick femur model was then used to investigate the potential 
synergistic effects between a known osteoinductive cue- BMP2 and mechano-activation of 
the Frizzled receptor. Injection of hMSC alone, or in conjunction with BMP2 releasing 
microparticles and/or L-UM206-MNP into the femur resulted in formation of secondary 
mineralisation sites most noticeable in the epiphysis (Fig. 6 A-C). Femurs were subjected to 
μCT analysis to assess changes in bone volume and density (Fig. 6A). Injection of hMSC 
alone led to increases in relative bone collar volume but had no overall effect on bone collar 
density compared to Sham injected control. In contrast, injection of hMSC with BMP2-
releasing microparticles, which provided an initial burst release of 60ng BMP2 followed by 
10ng/day, resulted in an increase in diaphyseal bone collar density but had no overall effect 
on bone collar volume (Fig 6b). Wnt pathway stimulation via L-UM206-MNP also resulted 
in an increase in relative bone collar density but had no overall effect on bone collar volume. 
The largest effects on bone formation were observed when femurs were injected with L-
UM206-MNP labelled MSC along with BMP2 releasing microparticles, which together 
caused an overall significant increase in relative bone collar density. Histological analysis of 
femurs confirmed the presence of secondary calcified mineralisation sites which were 
prevalent in the cell injected groups (with or without BMP2 and L-UM206-MNP) as shown 
by Alizarin red staining (Fig. 6C), whilst negligible mineralisation was observed in the sham 
injected groups. Cell injected groups were also positive for Osteocalcin as shown by 
Immunohistochemistry (Fig. 6C) and evidence of tissue remodelling by increased collagen 
and/or sGAG deposition was observed in all cell and L-UM206-MNP / BMP2 injected 
groups as shown by Alcian blue and Sirius red staining (Fig. 6C). 
  
Discussion 
In this study remote targeting and mechano-stimulation of Frizzled receptors for Wnt 
pathway activation using peptide-conjugated MNP has been demonstrated. It was also shown 
that this approach offers benefits in a bone tissue engineering context where the promotion of 
bone formation was achieved. In this investigation, UM206 peptides were coated onto 
magnetic nanoparticles and used to target MNP to Frizzled receptors at the cell membrane. 
This allowed remote stimulation of Wnt signal transduction by applying an external magnetic 
field to oscillate the particle-receptor complex using forces in the piconewton (pN: 10−12N) 
range as previously calculated [27]. The efficiency of the MNP coating procedure was 
characterised by examining changes in the physical characteristics of coated MNP and by 
monitoring unbound protein content in the coating solution supernatants. MNP 
functionalisation with UM206 peptides resulted in a decrease in free protein and an increase 
in relative particle size and surface charge. This could be attributed to the peptide layer 
conjugated to the MNP surface and is consistent with previous work which also showed 
alterations in MNP properties after functionalisation [14], [28]. Next we examined 
Frizzled2expression levels in MSC. MSC have previously been shown to express a number of 
Wnt ligands and receptors including Frizzled2 [2]. In this study, we also confirmed that MSC 
stably express Frizzled2 in basal or osteogenic media over three weeks. Our results also 
suggest that Frizzled2 expression is not regulated by short term stimulation with UM206-
MNP or exogenous Wnt3a. This is also consistent with previous work which demonstrated 
that Frizzled2 expression is not regulated by Wnt3a in hMSC [29]. The potential cytotoxic 
effects of MNP are an important consideration when developing MNP based tissue 
engineering treatments. Our experiments show that UM206 peptide alone or MNP bound 
UM206 with or without magnetic field stimulation has no obvious cytotoxic effects on hMSC 
at a range of doses. This finding agrees with previous studies which have shown the 
biocompatibility of iron-oxide based MNP in numerous cell types [30], [31], [32], [33], [34].  
Downstream indicators of Wnt pathway activation by UM206-MNP were investigated by 
assessing β-catenin localisation and end-point activation of TCF/LEF responsive signalling. 
Our results demonstrate that L-UM206-MNP (and to a lesser extent C-C-UM206-MNP) were 
capable of initiating nuclear translocation of β-catenin to a similar level as Wnt3a, this is 
comparable to other studies where Wnt has been shown to initiate β-catenin translocalisation 
[35]. In addition, our results demonstrate that L-UM206-MNP elevate downstream TCF/LEF 
expression after 6h which can be maintained up to 24h after treatment. In contrast, Wnt3a 
marginally elevated pathway activity after 6h but peak activity was observed after 24h, which 
suggests that L-UM206-MNP mediated activation may initiate a more rapid downstream 
activation. Interestingly, in contrast with L-UM206-MNP, particles coated with C-C-UM206 
peptide had a negligible effect on Wnt reporter activity and only marginally increased β-
catenin mobilisation. This may be a result of the lower binding affinity of the cyclic peptide 
compared to the linear peptide [13]. It is also possible that conjugation of multiple cyclic 
UM206 ligands to MNP may be inducing steric hindrance which may disrupt receptor 
binding affinity and reduce the signalling activity of the cyclic peptide. 
Our results demonstrated that pathway activation by L-UM206-MNP is not affected by 
DKK1, an inhibitor of the LRP co-receptor involved in canonical pathway activation, 
whereas Wnt3a mediated activation was successfully blocked with DKK1. This indicates that 
LRP is not involved in L-UM206-MNP mediated activation and suggests that MNP stimulate 
Wnt signalling by an alternative mechanism. This observation is in agreement with our 
previous work which has shown that antibody-MNP mediated Wnt pathway activation is also 
independent of LRP receptors [14]. We also employed a PLA assay to assess Frizzled 
receptor clustering as a potential mechanism by which L-UM206-MNP are inducing Wnt 
pathway activation. Our results indicate that L-UM206 (and to some extent C-C-UM206) 
functionalised MNP induce Frizzled2 dimerisation and clustering in distinct cell populations. 
Previous work from Liu et al demonstrated that adherent MSC cultures contain distinct sub-
populations which exhibit high endogenous Wnt signalling activity [36]. It is therefore 
possible that MNP may be inducing receptor clustering in this Wnt receptive population. 
Further work is required to elucidate the phenotype of these cells. Receptor clustering is a 
common mechanism of cell signalling activation and has previously been demonstrated using 
alternate magnetic particle activation systems [37]. Wnt pathway activation by receptor 
clustering has also been demonstrated in Xenopus embryos where Frizzled3 was found to 
form active dimers [38]. In contrast to UM206-MNP, no changes in receptor clustering were 
observed in Wnt3a treated cells. This can be expected as conventional signal activation by 
Wnt occurs through a complex of Wnt, Frizzled and LRP co-receptors and not necessarily 
through Frizzled dimers [39]. The mechano-responsiveness and activation of the Wnt 
pathway has been explored using other approaches. Fluid shear stress or mechanical strain 
using 4-point bending systems have been shown to initiate β-catenin translocation and 
activate TCF reporter systems [40], [41]. It is therefore possible that mechano-stimulation of 
Frizzled receptors using MNP is enough to induce a signalling response. Taken together, our 
results suggest a contrasting activation mechanism between MNP and native Wnt ligands. 
Our results confirm that Wnt pathway activation plays a role in hMSC osteogenesis. Wnt has 
been shown to have both inhibitory and promoting effects on MSC osteogenesis [5]. Our 
recent work utilising immobilised Wnt3a/collagen gel platforms has demonstrated the 
directional and inductive cues of a Wnt bound platform where MSCs located proximal to the 
Wnt signal maintain stem cell marker expression whilst migrated cells located distally to the 
Wnt signal display an osteogenic phenotype [9]. These results also agree with previous work, 
for example Wnt3a or GSK-3β inhibitors have been shown to promote MSC proliferation and 
maintain multipotency or promote MSC osteogenesis under certain doses and cellular 
contexts [6], [7], [42], [43]. In our studies intermittent stimulation of hMSC with L-UM206-
MNP over 28 days resulted in localised collagen synthesis, matrix maturation and 
mineralisation indicating a differentiated osteoblast phenotype. In contrast, treatment with 
Wnt3a for 28 days resulted in decreased mineralised matrix formation. This discrepancy 
could be explained by the contrasting dose-response effects of Wnt activation through MNP 
vs native Wnt. Our data suggest that Wnt pathway activation through L-UM206-MNP is a 
transient stimulus which is initially beneficial for hMSC lineage commitment to osteogenesis 
but enables terminal osteoblast differentiation after signal dissipation. Interestingly, this 
observation mirrors the effects of immobilised Wnt3a on MSC proliferation/differentiation 
seen by Lowndes et al [9] and also agrees with the findings of Ling et al [42] and Janeczek et 
al [44] who also showed that a transient Wnt signal is beneficial for hMSC commitment to 
the osteogenic lineage but withdrawal of Wnt is required for terminal osteoblast 
differentiation.  
The interactions between Wnt and other signalling pathways are complex [45]. Here we 
investigated the effects of combining Wnt stimulation via L-UM206-MNP with BMP2 
release from polymer microspheres which have applications in bone tissue engineering [46]. 
In these experiments we used the foetal chick femur, an established model of endochondral 
bone development [47], [48]. In this model, bone formation at the bone collar was increased 
by hMSC injection alone, whilst injection of BMP2 with hMSC or L-UM206-MNP labelled 
hMSC resulted in increases in bone density, indicating a more mature, functional matrix. The 
biggest increases in bone density were seen when L-UM206-MNP labelled MSC were co-
administered with BMP2 microspheres. During bone formation, Wnt and BMP2 have been 
shown to act reciprocally to regulate osteoblast differentiation [49]. Our previous work has 
also demonstrated the anabolic effects of BMP2 releasing microspheres [22]. The link 
between BMP2 and Wnt signalling has also been demonstrated by Vaes et al [50] who found 
that BMP2 signalling resulted in the upregulation of Wnt antagonists in the late phase of 
MSC differentiation. Considerable evidence also exists for the activation of TCF/LEF by 
both BMP/TGF and Wnt during development [51]. Therefore, the ability of L-UM206-MNP 
plus BMP2 to trigger bone formation could be attributed to the reciprocal relationship 
between Wnt and BMP signalling, where L-UM206-MNP act to initially trigger lineage 
commitment whilst BMP2 promotes terminal differentiation. This may explain why a 
combination of L-UM206-MNP and BMP2 resulted in the greatest enhancement of bone 
formation. Further work is required to fully explore the downstream signalling events in 
response to MNP stimulation and to establish the effects of cross-talk between MNP 
mediated Wnt signalling and the BMP pathway on cell signalling and phenotype.   
Using conjugated MNP to activate Wnt signalling may have useful applications as a research 
tool, in drug discovery and is amenable to translation to the clinic. Due to the expense and 
difficulty in preparing recombinant Wnt protein, easily synthesised ligands conjugated to 
magnetic nanoparticles present a viable method for the control of cell signalling and direction 
of cell differentiation. By initialising Wnt-Frizzled signalling in this manner, UM206-MNP 
may be able to over-ride many of the top-level inhibitors of Wnt signalling. Signalling 
activity can also be enhanced or reduced by operating an external magnetic switch, affording 
a degree of external control and temporal regulation of pathway activation. This magnetic 
activation approach has a beneficial impact on bone formation and works in synergy with 
bone promoting growth factors. This combinatorial strategy which utilises Stem cells with 
controlled release of clinically relevant growth factors and remote control over cell signalling 
is particularly attractive due to the relative ease by which this could be administered in the 
clinic in the form of an injectable cell therapy. Although this approach has particular 
relevance in bone tissue engineering for fracture repair, the wider applications of minimally 
invasive injectable cell therapies for tissue engineering are apparent.  
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   Fig. 1. Experimental setup schematic. (A) 250nm SPIO carboxy-dextran functionalised magnetic 
nanoparticles are covalently coated with UM206 peptide by carbodiimide activation (B) Human 
mesenchymal stem cells (hMSC) are then labelled with UM206-functionalised MNP, labelled cells 
can then be stimulated with oscillating magnetic fields. Alternatively, MNP-labelled cells can be 
injected into foetal chick femurs before magnetic field stimulation. (C) Alternating time-varied 
magnetic fields are applied to samples using a bioreactor system consisting of arrays of permanent 
rare earth magnets which situated beneath the samples. 
  
 
 
 
 
 
 
A B Fig. 2. Effects of MNP and magnetic field on cell toxicity and viability. (A) Immunofluorescence 
images showing L-UM206-MNP (middle) or C-C-UM206-MNP (right) labelled cells, MNP are shown 
by dextran staining (green). Nuclei are shown by DAPI staining (blue), cell cytoskeleton (red). 
Images representative of n=3, scale bar represents 50μm. (B) Immunofluorescence images 
showing Calcein-AM (Live) and Ethidium homodimer (Dead) staining after treatment with 25μg of 
L-/C-C-UM206-MNP, with and without magnetic field after 14 days. Representative images of n=3 
shown, scale bar represents 100µm. (C) Cell metabolism after treatment with L/C-C-UM206 MNP 
(with or without magnetic field). Average absorbance values are shown, n=3, error bars represent 
SEM. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. L-UM206-MNP activate Wnt signalling. Immunofluorescence images showing β-catenin 
mobilisation 24h after stimulation (A). Addition of Wnt3A-conditioned media (Wnt-CM) or L-
UM206-conjugated MNP resulted in increased nuclear translocation with further increases 
observed upon magnetic field stimulation. Cell nuclei are shown by DAPI staining (middle row). 
Scale bar represents 50µm. End point Wnt signalling was assessed using a TCF/LEF luciferase 
reporter 6h and 24h after treatment (C). Wnt3a-CM increased reporter activity after 6h and 24h 
(significant), and was blocked by Dickkopf-related protein 1 (DKK1). L-UM206-MNP significantly 
increased Wnt reporter activity at both time-points and was not affected by DKK1. L-UM206-
induced reporter activity was also significantly higher than in Wnt3a-CM groups at 6h (C(i)). This 
dataset is part of a larger dataset part of which has been published previously [14]. Treatment 
with C-C-UM206 MNP (C(ii)) had no overall effect on TCF/LEF reporter activity. Error bars 
represent SEM, n=4. * denotes p<0.05, # denotes p>0.05.  
  
 
 
 
 
 
 
 
  
Fig. 4. L-UM206-MNP induce Frizzled2 clustering. Frizzled2 receptor clustering was visualised 
using a PLA assay 3h after stimulation (A). Treatment with 25μg of L- / C-C-UM206-MNP (with or 
without magnetic field) resulted in clear increases in receptor clustering, whilst treatment with 
Wnt-CM had no effect. MNP are shown by dextran staining (green), Frizzled2 (red) and cell nuclei 
by DAPI staining (blue). Representative images of n=3 are shown. Scale bar represents 10μm. Co-
localisation analysis of ROI’s was used to determine the extent of MNP overlap with Frizzled2 
clusters (B). Clear regions of co-localisation (indicated by white regions) were observed in cells 
treated with L- / C-C-UM206-MNP (with or without magnetic field). Quantification of pixel overlap 
using Manders threshold coefficient for the MNP channel (tM2) confirmed a positive overlap 
between L- / C-C-UM206-MNP and Frizzled2 clusters. Representative images of n=3 are shown. 
Error represents SEM. 
Fig 5: L-UM206-MNP enhance matrix production. An increase in localised collagen deposition 
(Sirius red) (A), nodule formation (Alizarin red) (B) and Osteocalcin expression (C) was observed 
after treatment with L-UM206-MNP with magnetic field stimulation. Treatment with Wnt-CM 
caused an increase in collagen deposition (A) but a decrease in nodule formation (B), a minor 
increase in Osteocalcin expression (C) was also observed after 28 days. Cell nuclei are shown by 
DAPI staining, Images representative of n=4. Scale bar represents 200μm. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. L-UM206-MNP increase bone formation in chick femurs. (A) Injection of BMP2 releasing 
microparticles (and hMSC) led to increased bone volume but not bone density. Injecting L-
UM206-MNP labelled MSC with or without BMP2 resulted in increased bone density, n=8, Error 
bars represent SEM, * represents p<0.05. (B) Whole mount images showing calcium deposition 
(Alizarin red) primarily in the bone collar in all groups. Secondary mineralisation sites were 
observed at the microinjected epiphyseal regions injected with all hMSC groups. Scale bar 
represents 1mm. (C) Histological sections of all hMSC injected groups displayed evidence of the 
formation of secondary mineralisation (Alizarin red) as well as tissue remodelling (Alcian blue & 
Sirius red) and Osteocalcin positive matrix formation in the diaphyseal and epiphyseal injection 
sites of the femurs after 14 days. Representative images of n=8 shown. Scale bar represents 300 
µm (Alizarin red and Alcian blue/Sirius red), 400µm (Osteocalcin).  
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